The June 17 Windsor Brain Tumour Walk will raise funds for research, support programs, information, advocacy, awareness, and hope.
A $500,000 grant will fuel a project to research improvements in detecting potentially pandemic pathogens in the region of North America’s busiest border crossing.
Biochemistry professor Kenneth Ng is a member of a multidisciplinary group of UWindsor researchers partnering in an effort to enhance Canada’s preparedness for future pandemics.
Biomedical sciences major Teodora Taleski organized a fashion show that raised $5,000 to support the WE-Spark Health Institute.
Biomedical sciences major Teodora Taleski organized a fashion show that raised $5,000 to support the WE-Spark Health Institute.
Master’s student Tiana Visconti explores breast cancer treatment in the lab of WE-Spark Health Institute executive director Lisa Porter.
Bre-Anne Fifield is a member of a team exploring the role of a protein in developing liver cancer; the project has received a $750,000 research grant.
A team of UWindsor researchers has received a $750,000 grant to explore the role of a protein in developing liver cancer.
The Faculty of Science’s Women in Science group held a panel discussion to mark the International Day for Women and Girls in Science. Leaders speaking included (from left) Dora Cavallo-Medved, Arunita Jaekel, Isabelle Barrette-Ng, Shari Forbes, Maria Cioppa, Lisa Porter, Chitra Rangan, and Alice Grgicak-Mannion.
Ryan Palazzolo, WE-Spark Health Institute student network co-ordinator (centre), accepts an award for dedication to advancing its vision from executive director Lisa Porter and assistant director Karen Metcalfe.
Striking sparks: celebrating a new partner joining the WE-Spark Health Institute are officials (from left) Bill Marra of Hôtel-Dieu Grace Healthcare, Lisa Porter of WE-Spark Health Institute, Patti France of St. Clair College, Kristin Kennedy of Erie Shores HealthCare, David Musyj of Windsor Regional Hospital, and Chris Houser of the University of Windsor.
Research associate Dorota Lubanska is part of a team studying the use of nanoparticles to target and treat the aggressive brain cancer glioblastoma.
A research team is studying the use of nanoparticles to target and treat the aggressive brain cancer glioblastoma.
